CG Pharmaceuticals, Inc.
🇺🇸United States
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma
Phase 1
Recruiting
- Conditions
- Metastatic Pancreatic Adenocarcinoma
- Interventions
- First Posted Date
- 2022-02-21
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- CG Pharmaceuticals, Inc
- Target Recruit Count
- 70
- Registration Number
- NCT05249101
- Locations
- 🇺🇸
HonorHealth Research Institute, Scottsdale, Arizona, United States
🇺🇸Hoag Medical Group, Newport Beach, California, United States
🇺🇸UCSF Medical Center, San Francisco, California, United States
News
No news found